Werewolf Therapeutics Inc [HOWL] stock is trading at $0.7, up 16.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The HOWL shares have gain 19.24% over the last week, with a monthly amount glided 1.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Werewolf Therapeutics Inc [NASDAQ: HOWL] stock has seen the most recent analyst activity on December 19, 2025, when Wedbush downgraded its rating to a Neutral but kept the price target unchanged to $1 for it. Previously, JMP Securities started tracking the stock with Mkt Outperform rating on April 03, 2024, and set its price target to $12. On August 24, 2023, Wedbush initiated with an Outperform rating and assigned a price target of $9 on the stock. BofA Securities initiated its recommendation with a Buy and recommended $26 as its price target on September 10, 2021. SVB Leerink started tracking with an Outperform rating for this stock on May 25, 2021, and assigned it a price target of $29. In a note dated May 25, 2021, Jefferies initiated a Buy rating and provided a target price of $22 on this stock.
Werewolf Therapeutics Inc [HOWL] stock has fluctuated between $0.53 and $2.38 over the past year. Currently, Wall Street analysts expect the stock to reach $1 within the next 12 months. Werewolf Therapeutics Inc [NASDAQ: HOWL] shares were valued at $0.7 at the most recent close of the market. An investor can expect a potential return of 42.86% based on the average HOWL price forecast.
Analyzing the HOWL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.91, Equity is -1.44 and Total Capital is -1.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Werewolf Therapeutics Inc’s Current Ratio is 3.87. On the other hand, the Quick Ratio is 3.87, and the Cash Ratio is 3.73.
Transactions by insiders
Recent insider trading involved EVNIN LUKE, Director, that happened on Jan 16 ’26 when 38782.0 shares were sold. Director, EVNIN LUKE completed a deal on Jan 13 ’26 to sell 43198.0 shares. Meanwhile, Director EVNIN LUKE sold 37413.0 shares on Jan 15 ’26.
